The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

Part of paid clinical trials in Houston, Texas.

Sponsor
The University of Texas Health Science Center, Houston
Study ID
NCT06194344
Status
Recruiting

Conditions

  • Psychosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Individualized imagery — BEHAVIORAL
    Study personnel will assist participants to create scripts that foster relaxation and safety. Objects, places, and/or scenarios that foster participant relaxation, sense of safety, and/or positive emotions will be identified. Participants will write or type the generated scenario using highly detailed elements (e.g., including visual, olfactory, auditory, tactile, and gustatory sensations, as applicable) associated with the imagery. Study personnel will assist with recording the imagery scripts; audio files will be recorded using an audio recording application. The imagery scripts will be played at night via Bluetooth earbuds connected to the Muse app and script recording while laying down to sleep. The imagery rehearsal prompts will play for approximately 15 minutes, based on 10-20-minute recommendations across imagery rehearsal therapy (IRT) studies
  • Control — BEHAVIORAL
    Participants will wear the earbuds, with use of Muse S headband to collect outcome data without the individualized imagery scripts.

Study Details

The purpose of this study is to see how feasible is the use of compact EEG and paired audio technology to administer sleep interventions for inpatients with psychosis, to see if individuals that receive individualized technology-based sleep interventions experience improvements in sleep quality and to see if individuals that receive individualized technology-based sleep interventions experience improvements in symptomatology

Key Dates

Start date
Mar 5, 2024
Status verified
Jul 2025
Primary completion
Jun 1, 2026
Completion
Jun 1, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Individualized imagery
  • Active Comparator: Control

Primary Outcome Measure

Feasibility as assessed by coding percentage of use per night (based on duration of physiological measures collected per night divided by hours of sleep) [ Time Frame: from start of intervention to end of intervention (upto 80 days after baseline ) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of Texas Health Science Center at HoustonHoustonTexas77030
Alia Warner, Ph.D., ABPP
713-486-2700
Calvary Fielden
713-741-6087
Jessica Badawi, Ph.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

Related Studies